Junior De La Rosa Martinez

Junior De La Rosa Martinez

Auto-generated profile, based on publicly available information

Junior De La Rosa Martinez

Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond (A.T., J.D.L.R.M., K.A.E., J.K.).

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
ATAngkawipa Trongtorsak
Angkawipa Trongtorsak
JMJunior De La Rosa Martinez
Junior De La Rosa Martinez
TCThomas C. Crawford
Thomas C. Crawford
FBFrank Matthias Bogun
Frank Matthias Bogun
XGXiaokui Gu
Xiaokui Gu
FCfor the Cardiac Sarcoidosis Consortium
for the Cardiac Sarcoidosis Consortium
BACKGROUND: Differences in cardiac sarcoidosis between racial groups remain understudied. Therefore, this study aims to explore race differences in patients with cardiac sarcoidosis. METHODS: We analyzed data from the Cardiac Sarcoidosis Consortium, an international registry including over 25 centers. The primary clinical outcome was a composite end point of all-cause mortality, left ventricular assist device implantation, heart transplantation, or implantable cardioverter defibrillator therapy. RESULTS: A total of 619 patients were included in the study (362 White, 193 Black, and 64 other races). Black patients were diagnosed with cardiac sarcoidosis at a younger age (50.5±11.8 versus 53.7±10.5 years old; P =0.010) compared with White patients. Left ventricular ejection fraction was significantly lower in Black patients (44.6±15.4 versus 48.3±14.0; P =0.008). In addition, extracardiac involvement in the lungs (80.3% versus 72.7%; P =0.046), skin (22.8% versus 12.4%; p =0.002), and eyes (13.5% versus 5.5%; P =0.001) was more prevalent in Black patients. Patients had significantly higher rates of hypertension (69.9% versus 50.6%; P <0.001), diabetes (37.8% versus 21.0%; P <0.001), smoking (40.9% versus 26.8%; P <0.001), chronic obstructive pulmonary disease or emphysema (15.5% versus 4.1%; P <0.001), and chronic kidney disease (25.9% versus 12.4%; P 35% group (24.1% in Black versus 25.9% in White; P =0.72) and the left ventricular ejection fraction ≤35% group (51% versus 42.5%; P =0.35). CONCLUSIONS: Black patients with cardiac sarcoidosis exhibited significantly higher rates of lung, skin, and eye involvement and comorbidities, but had similar cardiac clinical outcomes and all-cause mortality compared with White patients. Nonetheless, ascertainment bias cannot be excluded.

23 September 2026 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
SCSherena L. Christmas
Sherena L. Christmas
RSRebecca I. Strauss
Rebecca I. Strauss
YSYigit K. Simsek
Yigit K. Simsek
MRMatthew I. Rosenthal
Matthew I. Rosenthal
OWOlivia A. White
Olivia A. White
LALizabeth A. Allison
Lizabeth A. Allison